Terminology Service for NFDI4Health
gp100:154-162 Peptide Vaccine
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2764
A peptide consisting of amino acid residues 154 through 162 of the melanoma-melanocyte antigen gp100. Vaccination with gp100:154-162 peptide may enhance tumor-specific T-cell immunity. gp100 antigen is a self-antigen expressed by melanocytes, pigmented retinal cells, and most melanoma lesions and is recognized via class I and II HLA-restricted mechanisms. [ ]
Term info
Label
gp100:154-162 Peptide Vaccine
Synonyms
- gp100:154-162 Peptide
- gp100:154-162 Peptide Vaccine
Subsets
NCIT_C128784
Has Target
http://purl.obolibrary.org/obo/NCIT_C2386
Legacy Concept Name
gp100_154-162_Peptide
NCI META CUI
CL053051
NSC Code
676540
PDQ Closed Trial Search ID
630596
PDQ Open Trial Search ID
630596
Preferred Name
gp100:154-162 Peptide Vaccine
Semantic Type
Pharmacologic Substance, Amino Acid, Peptide, or Protein
code
C2764
Term relations
Subclass of:
- Antineoplastic Vaccine
- Peptide Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Affects_Abnormal_Cell some Melanoma Cell
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation